Search research articles
Contact Us
Filters
Showing results (511-520 of 570) with videos related to
Page
of 57
Sort By:
JCO Clinical Cancer Informatics
|
October 18, 2021
Pediatric Cancer Data Commons: Federating and Democratizing Data for Childhood Cancer Research
Alejandro Plana, Brian Furner, Monica Palese, et al.
The Lancet. Oncology
|
December 2, 2019
A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study
Sheri L Spunt, Lynn Million, Yueh-Yun Chi, et al.
Nature Microbiology
|
January 9, 2019
Enabling genetic analysis of diverse bacteria with Mobile-CRISPRi
Jason M Peters, Byoung-Mo Koo, Ramiro Patino, et al.
Circulation. Genomic and Precision Medicine
|
March 28, 2025
DNA Damage Response and Repair Genes and Anthracycline-Induced Cardiomyopathy in Childhood Cancer Survivors: A Report From the Children's Oncology Group and the Childhood Cancer Survivor Study
Xuexia Wang, Purnima Singh, Romina B Cejas, et al.
JCO Precision Oncology
|
September 19, 2024
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I)
Margaret E Macy, Rajen Mody, Joel M Reid, et al.
EJC Paediatric Oncology
|
October 13, 2023
Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective
Kris Ann P Schultz, Murali Chintagumpala, Jin Piao, et al.
Journal of Clinical Medicine
|
April 30, 2021
Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force
Holly L Pacenta, Wendy Allen-Rhoades, David Langenau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2022
Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial
Olive S Eckstein, Carl E Allen, P Mickey Williams, et al.
Journal of the National Cancer Institute
|
December 29, 2020
Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group
He Li, Saumya D Sisoudiya, Bailey A Martin-Giacalone, et al.
JCO Precision Oncology
|
June 27, 2024
Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial
Kieuhoa T Vo, Amit J Sabnis, P Mickey Williams, et al.
Page
of 57
Search research articles
Search
Showing results (511-520 of 570) with videos related to
Sort By:
Page
of 57
JCO Clinical Cancer Informatics
|
October 18, 2021
Pediatric Cancer Data Commons: Federating and Democratizing Data for Childhood Cancer Research
Alejandro Plana, Brian Furner, Monica Palese, et al.
The Lancet. Oncology
|
December 2, 2019
A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study
Sheri L Spunt, Lynn Million, Yueh-Yun Chi, et al.
Nature Microbiology
|
January 9, 2019
Enabling genetic analysis of diverse bacteria with Mobile-CRISPRi
Jason M Peters, Byoung-Mo Koo, Ramiro Patino, et al.
Circulation. Genomic and Precision Medicine
|
March 28, 2025
DNA Damage Response and Repair Genes and Anthracycline-Induced Cardiomyopathy in Childhood Cancer Survivors: A Report From the Children's Oncology Group and the Childhood Cancer Survivor Study
Xuexia Wang, Purnima Singh, Romina B Cejas, et al.
JCO Precision Oncology
|
September 19, 2024
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I)
Margaret E Macy, Rajen Mody, Joel M Reid, et al.
EJC Paediatric Oncology
|
October 13, 2023
Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective
Kris Ann P Schultz, Murali Chintagumpala, Jin Piao, et al.
Journal of Clinical Medicine
|
April 30, 2021
Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force
Holly L Pacenta, Wendy Allen-Rhoades, David Langenau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2022
Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial
Olive S Eckstein, Carl E Allen, P Mickey Williams, et al.
Journal of the National Cancer Institute
|
December 29, 2020
Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group
He Li, Saumya D Sisoudiya, Bailey A Martin-Giacalone, et al.
JCO Precision Oncology
|
June 27, 2024
Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial
Kieuhoa T Vo, Amit J Sabnis, P Mickey Williams, et al.
Page
of 57